Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement
Briefly

The settlement approved by all 50 states and U.S. territories involves Purdue Pharma, the maker of Oxycontin, and addresses the implications of their marketing practices linked to the opioid epidemic. Filed in federal bankruptcy court, the plan includes over $7 billion from the Sackler family while allowing creditors to pursue separate lawsuits against them. New York's Attorney General Letitia James emphasized the accountability of the Sackler family, while legal representatives celebrate the funds designated to support communities dealing with opioid addiction, pending federal court approval.
The $7.4 billion settlement with Purdue Pharma addresses the company's improper marketing of opioids and aims to provide funds for communities recovering from the crisis.
The Sackler family, owners of Purdue Pharma, are expected to contribute up to $7 billion, but maintain claims of having done nothing wrong.
Read at www.npr.org
[
|
]